Small Cell Lung Cancer (SCLC) Treatments
Find Small Cell Lung Cancer (SCLC) Treatments
Hycamtin
What is Hycamtin (Topotecan)?
Top Global Experts
Related Clinical Trials
Summary: This phase III trial tests how well the addition of dinutuximab to Induction chemotherapy along with standard of care surgical resection of the primary tumor, radiation, stem cell transplantation, and immunotherapy works for treating children with newly diagnosed high-risk neuroblastoma. Dinutuximab is a monoclonal antibody that binds to a molecule called GD2, which is found on the surface of neur...
Summary: This study will evaluate the safety and efficacy of R-DXd therapy in participants with ovarian, peritoneal, or fallopian tube cancer.
Summary: Pediatric soft tissue sarcomas (STS) are a group of malignant tumors originating from primitive mesenchymal tissues and account for approximately 7% of childhood cancers. STS are broadly classified into rhabdomyosarcoma (RMS) and non-rhabdomyosarcoma soft tissue sarcoma (NRSTS). RMS accounts for approximately one half of pediatric STS. As reported, PAX fusion-positive RMS is more aggressive than f...
Related Latest Advances
Brand Information
- 0.25 mg: opaque white to yellowish-white and imprinted with HYCAMTIN and 0.25 mg.
- 1 mg: opaque pink and imprinted with HYCAMTIN and 1 mg.
- Myelosuppression
- Diarrhea
- Interstitial Lung Disease (ILD)
- Gastrointestinal: Gastrointestinal perforation
- General and Administration Site Conditions: Mucosal inflammation Hypersensitivity: Allergic manifestations, anaphylactoid reactions, angioedema

- “OSHA Hazardous Drugs.”
- Advise the patient to read the FDA-approved patient labeling (Patient Information).
- Inform patients that HYCAMTIN capsules can cause diarrhea which may be severe and life-threatening. Instruct patients how to manage and/or prevent diarrhea and to inform their physician if severe diarrhea occurs during treatment with HYCAMTIN capsules

